EUA
Clear Dx SARS-CoV-2 WGS v3.0 Test
FDA Emergency Use Authorization · Laboratory Corporation of America (Labcorp) · Dec 6, 2023
Key facts
| Product | Clear Dx SARS-CoV-2 WGS v3.0 Test |
|---|---|
| Company | Laboratory Corporation of America (Labcorp) |
| Product type | Next Generation Sequencing (NGS), PANGO lineage |
| Date | Dec 6, 2023 |
| FDA page | fda.gov |
At a glance
- 1–9 Authorization documents
- 1–9 EUAs for this company
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Emergency Use Authorizations
Emergency Use Authorizations allow the FDA to permit unapproved medical products, or unapproved uses of approved products, during a declared public health emergency.
Source: U.S. Food and Drug Administration (FDA), Emergency Use Authorizations · Source date: